1. Home
  2. Labeler Index
  3. N&b Lab.co.ltd
  4. NDC Product Code: 69058-200 Maxclinic Miraclinic Contour Ing Object

NDC 69058-200 Maxclinic Miraclinic Contour Ing Object

View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. What is NDC 69058-200?
  4. Maxclinic Miraclinic Contour Ing Object Uses
  5. Active Ingredients UNII Codes
  6. Inactive Ingredients UNII Codes

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Get all the details for National Drug Code (NDC) 69058-200 in one place. This page breaks down everything you need to know about the NDC, including proprietary name, active and inactive substances, package configurations, billing units, labeler information, and routes of administration. It also includes enhanced data such as HCPCS codes, FDA product labels with images, UNIIs, and RxNorm cross-references. Whether you're a healthcare professional verifying drug data or a consumer researching medication, this NDC page helps you make informed, accurate decisions.

NDC Product Code:
69058-200
Proprietary Name:
Maxclinic Miraclinic Contour Ing Object
Product Type: [3]
Labeler Name: [5]
N&b Lab.co.ltd
Labeler Code:
69058
Product Label ID:
d2850be8-3cc3-4da2-a6bd-0fdadfb19782
Marketing Category: [8]
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date: [9]
11-01-2016
End Marketing Date: [10]
12-31-2016
Listing Expiration Date: [11]
12-31-2016
Exclude Flag: [12]
D
Code Navigator:

Code Structure Chart

Product Details

What is NDC 69058-200?

The NDC code 69058-200 is assigned by the FDA to the product Maxclinic Miraclinic Contour Ing Object which is product labeled by N&b Lab.co.ltd. The product's dosage form is . The product is distributed in a single package with assigned NDC code 69058-200-02 1 pouch in 1 carton / 24 g in 1 pouch (69058-200-01). This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Maxclinic Miraclinic Contour Ing Object?

Indications & usage: 1. Take out top part of MIRACLINIC ampoule dressing(no.1) and place it up aligning holes with eyes. 2. Take out lower part of ampoule dressing(no.1) place it aligning hole with lips, and over jaw line by holding it up (Adheres better when pulling it up since material is stretchy) 3. Take out lower part of ampoule dressing(no.1) place it aligning hole with lips, and over jaw line by holding it upm (Adheres better when pulling it up since material is stretchy) 4. Take out countouring object(no,2) and place from forehead, cheeks and mouth area slowing on top of ampoule dressing. 5. Adhere jaw area mask by pulling it up along facial line. 6. Gently press face with both hands supporting facial line. Supporting facial line. Adheres better if plaster is pressed till moist. 7. Take off plaster once tapping and checking plaster on cheecks is hardened after 20~30 minutes. 8. Take off the mask sheet. Remove remaining plaster from the face and finish with applying essence.

Which are Maxclinic Miraclinic Contour Ing Object UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Maxclinic Miraclinic Contour Ing Object Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[10] What is the End Marketing Date? - This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".